BTX is committed to creating a world in which patients and families with high unmet medical needs have access to effective treatments.
Employees: 11-50
Founded date: 1994
Investors 1
Date | Name | Website |
06.05.2021 | Disruptive... | disruptive... |
Mentions in press and media 3
Date | Title | Description | Source |
14.06.2021 | Brooklyn ImmunoTherapeutics : Executes Letter of Intent to B... | News & Events Brooklyn ImmunoTherapeutics Executes Letter of Intent to Buy Novellus Therapeutics... | marketscre... |
15.03.2021 | NTN Buzztime Announces Approval of Merger with Brooklyn Immu... | CARLSBAD, Calif., March 15, 2021 /PRNewswire/ -- NTN Buzztime, Inc. (NYSE American: NTN) today ann... | prnewswire... |
- | COVID-19 vaccines revolutionized RNA — now everyone else wan... | Employees in special suits test procedures for manufacturing the messenger-RNA COVID-19 vaccine from... | businessin... |